杂志简称：j asthma
中文译名：《哮喘杂志》
收录属性：高质量科技期刊（t2）, scie（2024版）, 目次收录（维普）,英文期刊,
自引率：9.00%
投稿方向：医学、allergy过敏、respiratory system呼吸系统
SCI/E期刊基本信息
出版周期：月刊 地区：美国
中科院分区：4区
是否TOP：非TOP期刊
是否综述：非综述期刊
是否OA：非OA期刊
国际标准刊号：ISSN 0277-0903/EISSN 1532-4303
杂志语言：英语
出版国家：美国
杂志官网 联系方式
出版地址：TAYLOR & FRANCIS INC,325 CHESTNUT ST,SUITE 800,PHILADELPHIA,USA,PA,19106
杂志邮箱：
投稿网址：https://mc.manuscriptcentral.com/ljas
杂志官方网址：https://www.tandfonline.com/toc/ijas20/current
出版商网址：https://www.tandfonline.com/
杂志投稿要求
投稿须知
【杂志社官方网站信息】
Instructions for authors
Preparing Your Paper
All authors submitting to medicine, biomedicine, health sciences, allied and public health journals should conform to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals, prepared by the International Committee of Medical Journal Editors (ICMJE).
Article Types
Original Articles, Review Articles, Letters to the Editor, Commentaries, Book Reviews, Case Studies
Should be written with the following elements in the following order: title page; abstract; keywords; main text introduction, materials and methods, results, discussion; acknowledgments; declaration of interest statement; references; appendices (as appropriate); table(s) with caption(s) (on individual pages); figures; figure captions (as a list)
Should be no more than 4000 words, inclusive of:
Tables
Should contain an unstructured abstract of 250 words.
Read making your article more discoverable, including information on choosing a title and search engine optimization.
All Submissions should have a maximum of 60 references and a combined total of 8 tables and/or figures. Manuscripts in excess of 5,000 words will be considered at the Editor’s discretion. Note: Journal of Asthma will not consider for publication manuscripts on research funded by tobacco companies. Manuscripts should be compiled in the following order: Title page containing running head and keywords; Main text; Acknowledgments (if applicable); Declaration of Interest statement (mandatory); References; Appendices (if applicable); Tables with captions; Figures; and Figure captions. Title Page Provide a title page with your submission, including in it the manuscript title and names and affiliations of all authors. Clearly designate the corresponding author and his/her full contact information, including phone number and email address. Please include the running head of no more than 50 characters. At least 5-7 keywords that are not in the title or the journal name should also be included on the title page. These keywords will assist indexers in cross-indexing the article, and should therefore be included in the abstract. Main Text All articles should start with an unstructured abstract of no more than 250 words. The Abstract must be divided up under the following headings: Objective, Methods, Results and Conclusions. Original articles The body of original articles should include the following distinct sections: Introduction: This section should state the background to and purpose of the study. Methods: Please identify the methods, mechanisms, and procedures in sufficient detail to allow others to reproduce the results, and describe statistical methods with enough detail to enable a knowledgeable reader with access to the original data to verify the reported results. Journal of Asthma requires that studies involving animals/humans be approved by an institutional review board, in accordance with approved published guidelines, prior to actually performing the research and publishing the data. This approval should be explicitly stated in the methods section. Please also see the section on Ethics and Consent and Statistical Notes. Results: Please present your results concisely and accurately. For studies reporting clinical trials, include the sample size of each data point, with p-values and confidence intervals quoted for both significant and non-significant findings. Discussion: This should include implications of the findings and their limitations, with reference to other relevant studies and the possibilities these suggest for future research. Conclusions/key findings: This section should be distinct from the Discussion section and should concisely summarize the clinical implications or key research findings. Review Articles The body of a review article should be a comprehensive, scholarly evidence-based review of the literature, accompanied by critical analysis and leading to reasonable conclusions. Wherever appropriate, details of the literature search methodology should be provided, i.e. the databases searched, the search terms and inclusive dates, and any selectivity criteria imposed. Wherever possible, use primary resources, avoiding “Data on File”, “Poster” or other unpublished references. Review articles address a specific question or issue that is relevant for clinical practice and provide an evidence-based, balanced, patient-oriented review on a focused topic, either clinical or basic science. Because of space limitations, the review is not intended to be exhaustive – it should be directed. These articles should focus on current advancements in the field, and should be based on the latest “cutting-edge” clinical, translational, or basic science. Review Articles should have a structured abstract of no more than 255 words with the following headings: Objective, Data Sources, Study Selections, Results, and Conclusion. A maximum of 12 keywords and 60 references are allowed. Text should not exceed 4,000 words and should be organized into the following sections: Introduction, Methods, Results, Discussion and Conclusion. Case Studies Only properly formatted and relevant Case Studies will be considered for publication. Abstracts should be formatted with: Introduction; Case Study; Results; Conclusion. The Main Text should be formatted as: Introduction; Case Study; Results; Discussion; Conclusion. Letters to the Editor Letters to the Editor will be considered for publication subject to editor approval and provided that the content relates to articles published in the journal. Letters should be received less than six months after publication of the original work in question. Pending editor approval, letters will be submitted to the author of the original paper in order that a reply can be published simultaneously. Commentaries All commentary topics must be checked with the editor prior to submission. Commentaries should be knowledge-based or consensus-type articles (e.g. working group statement) expressing objective opinions, experiences or perspectives on an important area related to asthma. Book Reviews Journal of Asthma considers a limited number of book reviews. Book review ideas must be checked with the editor prior to submission. Acknowledgments section Please read the Ethics and Consent below for information about this optional section. In short, the Acknowledgments section details special thanks, personal assistance, and dedications. Acknowledgments should be included in a separate headed section at the end of the manuscript preceding any appendices, and before the Declaration of Interest Section. Declaration of Interest section It is the policy of all Informa Healthcare, to adhere in principle to the Conflict of Interest policy recommended by the International Committee of Medical Journal Editors (ICMJE). (http://www.icmje.org/index.html#conflict) All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. It is the sole responsibility of authors to disclose any affiliation with any organization with a financial interest, direct or indirect, in the subject matter or materials discussed in the manuscript (such as consultancies, employment, paid expert testimony, honoraria, speakers bureaus, retainers, stock options or ownership, patents or patent applications or travel grants) that may affect the conduct or reporting of the work submitted. All sources of funding for research are to be explicitly stated. If uncertain as to what might be considered a potential conflict of interest, authors should err on the side of full disclosure. All submissions to the journal must include full disclosure of all relationships that could be viewed as presenting a potential conflict of interest. If there are no conflicts of interest, authors should state that there are none. This must be stated at the point of submission (within the manuscript after the main text under a subheading “Declaration of interest” and where available within the appropriate field on the journal’s Manuscript Central site). This may be made available to reviewers and will appear in the published article at the discretion of the Editors or Publisher. If no conflict is declared, the following statement will be attached to all articles: Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper. The intent of this policy is not to prevent authors with these relationships from publishing work, but rather to adopt transparency such that readers can make objective judgments on conclusions drawn.
Style Guidelines
Please refer to these quick style guidelines when preparing your paper, rather than any published articles or a sample copy.
Please use American spelling style consistently throughout your manuscript.
Please use double quotation marks, except where “a quotation is ‘within’ a quotation”.
Please note that long quotations should be indented without quotation marks.
Please note the following general style guidelines:
Do not use the term “significant” unless p-values are provided. Show p-values as <0.001 or to 2 or 3 decimal places
Cases of tuberculosis and designators of mycobacteria should be classified according to the American Lung Association’s Diagnostic Standards and Classification of Tuberculosis (1990)
When a trademarked pharmaceutical or other product is named in the research, it must be accompanied by the generic name as well. According to journal style, after first mention, only the generic name should be used. Do not use proprietary names in article titles or in the abstract
Latin terminology, including microbiological and species nomenclature, should be italicized
Use standard convention for human and animal genes and proteins: italics for genes and regular font for proteins, and upper case for human products and lower case for animal products
Units and Measurement: the Système International (SI) system should be used for all scientific units. Authors can refer to the SI Conversion Calculator on the AMA Manual of Style website to convert conventional units into SI units.
Upper case characters in headings and references should be used sparingly, e.g. only the first word of paper titles, subheadings and any proper nouns begin upper case; similarly for the titles of papers from journals in the references and elsewhere
All acronyms for national agencies, examinations, etc., should be spelled out the first time they are introduced in text or references. Thereafter the acronym can be used if appropriate, e.g. “The work of the Assessment of Performance Unit (APU) in the early 1980s …” and subsequently, “The APU studies of achievement …”, in a reference “(Department of Education and Science [DES] 1989a)”
Wherever possible, avoid labelling people according to their disability or disease. Instead, use person-first language (patients diagnosed with COPD, children with asthma, etc)
As per AMA style, please do not use commas in numbers with more than three digits. In 4-digit numbers, the digits are set closed up. For numbers of 10 000 or greater, a half-space or thin space is used to separate every digit from the right-most integer or decimal point
Formatting and Templates
Papers may be submitted in Word format. Figures should be saved separately from the text. To assist you in preparing your paper, we provide formatting template(s).
Word templates are available for this journal. Please save the template to your hard drive, ready for use.
If you are not able to use the template via the links (or if you have any other template queries) please contact us here.
Tables
Lines of data should not be numbered. When referring to tables in the text, please use Arabic numbers (rather than Roman numerals). Tables should be grouped at the end of the manuscript on separate pages. If the tables are in Microsoft Word format, they can be submitted at the end of the text in the same file as the text. However, if they are in formats other than Microsoft Word, such as in Excel, the tables should be submitted separately.
Footnotes to tables should be typed directly below the table and be indicated per American Medical Association (AMA) guidelines by lowercase alphabetic superscripts.
Figures and Illustrations
Illustrations (line drawings, halftones, photos, photomicrographs, etc.) and figures should be submitted as digital files for highest quality reproduction and should follow these guidelines:
300 dpi or higher
Sized to fit on journal page
EPS, JPG, TIFF, PowerPoint, or PSD format only
All illustrations should be submitted as separate files, not embedded in the text
Legends or captions for figures should be listed on a separate page, double spaced
For information on submitting animations, movie files, and sound files, or for any additional information including indexes and calendars, please click here.
For information on color figure charges, please see Production and Proofs.
Statistical Notes
All articles reporting on clinical trials should conform to the CONSORT statement. These studies should contain details of the study population and setting; subject selection (inclusion/exclusion criteria); methods of randomization and blinding; and efficacy and safety measures. The study design and statistical methodology should be described, along with justification for the choice of analysis and sample size given. Statistical methods used to compare groups for primary outcomes should specify what type of confidence interval was employed, and any additional methods for analyses (subgroup, adjusted) should be reflected as well. The sample size of each data point should be shown, with p-values and confidence intervals quoted for both significant and non-significant findings.
Genomics Data
Ensure all data collected and analyzed in the research adhere to the Minimal Information About a Microarray Experiment (MIAME) guidelines. The MIAME checklist is available
at: http://www.mged.org/Workgroups/MIAME/miame-checklist.html. Journal of Asthma requires all primary microarray data be submitted to an appropriate public repository (ArrayExpress, GEO, or CIBEX) in a format that complies with the MIAME guidelines. Deposit nucleic acid and protein sequences in EMBL or Genbank databases and provide accession numbers in the manuscript.
Allergen Data
If a manuscript includes a new or unnamed allergen, please contact the WHO/IUIS Allergen Nomenclature Sub-Committee for approval of new nomenclature. For more information, please visit www.allergen.org.
References
Please use this reference guide when preparing your paper.
Taylor & Francis Editing Services
To help you improve your manuscript and prepare it for submission, Taylor & Francis provides a range of editing services. Choose from options such as English Language Editing, which will ensure that your article is free of spelling and grammar errors, Translation, and Artwork Preparation. For more information, including pricing, visit this website.
Checklist: What to Include
Author details. Please ensure everyone meeting the International Committee of Medical Journal Editors (ICMJE) requirements for authorship is included as an author of your paper. All authors of a manuscript should include their full name and affiliation on the cover page of the manuscript. Where available, please also include ORCiDs and social media handles (Facebook, Twitter or LinkedIn). One author will need to be identified as the corresponding author, with their email address normally displayed in the article PDF (depending on the journal) and the online article. Authors’ affiliations are the affiliations where the research was conducted. If any of the named co-authors moves affiliation during the peer-review process, the new affiliation can be given as a footnote. Please note that no changes to affiliation can be made after your paper is accepted. Read more on authorship.
You can opt to include a video abstract with your article. Find out how these can help your work reach a wider audience, and what to think about when filming.
Funding details. Please supply all details required by your funding and grant-awarding bodies as follows:
For single agency grants
This work was supported by the [Funding Agency] under Grant [number xxxx].
For multiple agency grants
This work was supported by the [Funding Agency #1] under Grant [number xxxx]; [Funding Agency #2] under Grant [number xxxx]; and [Funding Agency #3] under Grant [number xxxx].
Disclosure statement. This is to acknowledge any financial interest or benefit that has arisen from the direct applications of your research. Further guidance on what is a conflict of interest and how to disclose it.
Data availability statement. If there is a data set associated with the paper, please provide information about where the data supporting the results or analyses presented in the paper can be found. Where applicable, this should include the hyperlink, DOI or other persistent identifier associated with the data set(s). Templates are also available to support authors.
Data deposition. If you choose to share or make the data underlying the study open, please deposit your data in a recognized data repository prior to or at the time of submission. You will be asked to provide the DOI, pre-reserved DOI, or other persistent identifier for the data set.
Supplemental online material. Supplemental material can be a video, dataset, fileset, sound file or anything which supports (and is pertinent to) your paper. We publish supplemental material online via Figshare. Find out more about supplemental material and how to submit it with your article.
Figures. Figures should be high quality (1200 dpi for line art, 600 dpi for grayscale and 300 dpi for colour, at the correct size). Figures should be supplied in one of our preferred file formats: EPS, PS, JPEG, TIFF, or Microsoft Word (DOC or DOCX) files are acceptable for figures that have been drawn in Word. For information relating to other file types, please consult our Submission of electronic artwork document.
Tables. Tables should present new information rather than duplicating what is in the text. Readers should be able to interpret the table without reference to the text. Please supply editable files.
Equations. If you are submitting your manuscript as a Word document, please ensure that equations are editable. More information about mathematical symbols and equations.
Units. Please use SI units (non-italicized).
Using Third-Party Material
You must obtain the necessary permission to reuse third-party material in your article. The use of short extracts of text and some other types of material is usually permitted, on a limited basis, for the purposes of criticism and review without securing formal permission. If you wish to include any material in your paper for which you do not hold copyright, and which is not covered by this informal agreement, you will need to obtain written permission from the copyright owner prior to submission. More information on requesting permission to reproduce work(s) under copyright.